The Friedrich Miescher Institute for Biomedical Research (FMI) is a world-class biomedical research institute affiliated with the University of Basel and Novartis Biomedical Research. Named after Friedrich Miescher, the Basel biochemist who discovered nucleic acids, the FMI was founded in 1970 by Ciba and Geigy — Novartis’ predecessor companies — to bridge academic research and the pharmaceutical industry. With an international staff of about 330 people, including more than 150 postdoctoral fellows and graduate students, the FMI conducts cutting-edge research in genome regulation, multicellular systems and neurobiology. The FMI is located in the vibrant city of Basel, Switzerland’s third-largest city and Europe’s leading hub for the life sciences.